BTAI
Price
$1.65
Change
-$0.04 (-2.37%)
Updated
Jun 17, 11:30 AM (EDT)
Capitalization
9.45M
ORMP
Price
$2.16
Change
-$0.00 (-0.00%)
Updated
Jun 17, 01:45 PM (EDT)
Capitalization
88.24M
57 days until earnings call
Interact to see
Advertisement

BTAI vs ORMP

Header iconBTAI vs ORMP Comparison
Open Charts BTAI vs ORMPBanner chart's image
BioXcel Therapeutics
Price$1.65
Change-$0.04 (-2.37%)
Volume$200
Capitalization9.45M
Oramed Pharmaceuticals
Price$2.16
Change-$0.00 (-0.00%)
Volume$500
Capitalization88.24M
BTAI vs ORMP Comparison Chart in %
Loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. ORMP commentary
Jun 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a StrongBuy and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 17, 2025
Stock price -- (BTAI: $1.69 vs. ORMP: $2.16)
Brand notoriety: BTAI and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 48% vs. ORMP: 28%
Market capitalization -- BTAI: $9.45M vs. ORMP: $88.24M
BTAI [@Biotechnology] is valued at $9.45M. ORMP’s [@Biotechnology] market capitalization is $88.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $356.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than BTAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 2 bullish TA indicator(s).

  • BTAI’s TA Score: 5 bullish, 5 bearish.
  • ORMP’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, BTAI is a better buy in the short-term than ORMP.

Price Growth

BTAI (@Biotechnology) experienced а -13.78% price change this week, while ORMP (@Biotechnology) price change was -3.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.50%. For the same industry, the average monthly price growth was +15.92%, and the average quarterly price growth was +9.45%.

Reported Earning Dates

BTAI is expected to report earnings on May 12, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+2.50% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($88.2M) has a higher market cap than BTAI($9.45M). ORMP YTD gains are higher at: -10.744 vs. BTAI (-71.750). ORMP has higher annual earnings (EBITDA): -21.53M vs. BTAI (-24.24M). ORMP has more cash in the bank: 131M vs. BTAI (31M). ORMP has less debt than BTAI: ORMP (301K) vs BTAI (106M). ORMP has higher revenues than BTAI: ORMP (2M) vs BTAI (1.85M).
BTAIORMPBTAI / ORMP
Capitalization9.45M88.2M11%
EBITDA-24.24M-21.53M113%
Gain YTD-71.750-10.744668%
P/E RatioN/A20.91-
Revenue1.85M2M93%
Total Cash31M131M24%
Total Debt106M301K35,216%
FUNDAMENTALS RATINGS
BTAI vs ORMP: Fundamental Ratings
BTAI
ORMP
OUTLOOK RATING
1..100
3113
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
6577
P/E GROWTH RATING
1..100
10050
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (58) in the Pharmaceuticals Other industry is in the same range as BTAI (81) in the Biotechnology industry. This means that ORMP’s stock grew similarly to BTAI’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as BTAI (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to BTAI’s over the last 12 months.

ORMP's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as BTAI (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to BTAI’s over the last 12 months.

BTAI's Price Growth Rating (65) in the Biotechnology industry is in the same range as ORMP (77) in the Pharmaceuticals Other industry. This means that BTAI’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (50) in the Pharmaceuticals Other industry is somewhat better than the same rating for BTAI (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than BTAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BTAIORMP
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 30 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ILAG0.530.06
+11.63%
Intelligent Living Application Group
EQT58.171.33
+2.34%
EQT Corp
GRWG1.160.02
+1.75%
GrowGeneration Corp
AROC24.56-0.26
-1.05%
Archrock
KARO45.83-2.41
-5.00%
Karooooo Ltd

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with ORMP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
+8.33%
ORMP - BTAI
44%
Loosely correlated
+1.89%
AXON - BTAI
42%
Loosely correlated
-0.00%
INO - BTAI
39%
Loosely correlated
N/A
IGMS - BTAI
38%
Loosely correlated
+0.83%
ARRY - BTAI
37%
Loosely correlated
N/A
More